Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery

Background Bariatric-metabolic surgery (BS) decreases the grade of steatosis, hepatic inflammation, and fibrosis in patients with severe obesity and non-alcoholic fatty liver disease (NAFLD). Mechanisms include substantial weight loss, but also simultaneous effects on glucose homeostasis. Therefore,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Obesity surgery 2023-02, Vol.33 (2), p.530-538
Hauptverfasser:	Lautenbach, Anne, Wernecke, Marie, Mann, Oliver, Wagner, Jonas, Wolter, Stefan, Stoll, Fabian, Aberle, Jens
Format:	Artikel
Sprache:	eng
Schlagworte:	Bariatric Surgery Diabetes Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - surgery Fibrosis Gastrectomy - methods Gastric Bypass - methods Gastrointestinal surgery Humans Inflammation - complications Liver Medicine Medicine & Public Health Metabolism Non-alcoholic Fatty Liver Disease - complications Non-alcoholic Fatty Liver Disease - surgery Obesity - surgery Obesity, Morbid - surgery Original Contributions Retrospective Studies Surgery Treatment Outcome Weight control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!